Document is current
Any future updates will be listed below
-
Authors
Köylüce, Serpil https://orcid.org/0000-0002-6755-9074
Açar, Elif https://orcid.org/0000-0002-4669-5034
Şeker, Serhat https://orcid.org/0000-0002-2852-6181
Yılmaz, Hatice Eylül Bozkurt https://orcid.org/0000-0001-7499-8676
Yapıcı, Elif Aktaş https://orcid.org/0000-0002-2786-8489
Arslan, Bahar https://orcid.org/0000-0001-6023-6291
Yılmaz, Insu
Türk, Murat https://orcid.org/0000-0002-3290-2661
- License Information
-
More Information
Article History
Received: 16 February 2025
Revised: 4 June 2025
Accepted: 24 June 2025
First Online: 5 July 2025
Declarations
:
: MT has no relevant conflict of interest in this work. MT is or recently was a speaker and/or advisor for Abdi İbrahim, AstraZeneca, Chiesi, GSK, Novartis, ROXALL, and Vem İlaç. İY has no relevant conflict of interest concerning this work. İY is or recently was a speaker and/or advisor for Abdi İbrahim, AstraZeneca, Chiesi, GSK, Novartis, Bilim, and Polifarma. Other authors involved in this research have no conflict of interest to declare, ensuring the integrity and impartiality of our findings.
